← Back to Screener
CONMED Corporation (CNMD)
Price$39.08
Favorite Metrics
Price vs S&P 500 (26W)-17.18%
Price vs S&P 500 (4W)-0.76%
Market Capitalization$1.20B
P/E Ratio (Annual)25.61x
Indicated Dividend Yield (Annual)2.11%
All Metrics
P/CF (Annual)7.06x
Book Value / Share (Quarterly)$33.36
P/TBV (Annual)2.79x
Indicated Dividend (Annual)$0.80
Revenue Growth (3Y)9.55%
Cash Flow / Share (Quarterly)$4.87
Payout Ratio (TTM)52.59%
Price vs S&P 500 (YTD)-7.88%
Gross Margin (TTM)54.59%
Net Profit Margin (TTM)3.42%
EPS (TTM)$1.51
10-Day Avg Trading Volume0.39M
EPS Excl Extra (TTM)$1.51
Revenue Growth (5Y)9.77%
EPS (Annual)$1.51
Dividend / Share (Annual)$0.80
ROI (Annual)2.52%
Gross Margin (Annual)53.87%
Net Profit Margin (5Y Avg)3.44%
Cash / Share (Quarterly)$1.32
P/E Basic Excl Extra (TTM)25.61x
Revenue Growth QoQ (YoY)7.88%
EPS Growth (5Y)36.23%
P/E Normalized (Annual)25.61x
ROA (Last FY)2.02%
Revenue Growth TTM (YoY)5.18%
EBITD / Share (TTM)$4.42
ROE (5Y Avg)4.64%
Operating Margin (TTM)7.46%
Cash Flow / Share (Annual)$4.87
P/B Ratio1.17x
P/B Ratio (Quarterly)1.22x
Net Income / Employee (Annual)$0
EV / Revenue (TTM)1.45x
Net Interest Coverage (TTM)3.29x
ROA (TTM)2.03%
EPS Growth QoQ (YoY)-51.02%
EV / EBITDA (TTM)14.55x
EPS Incl Extra (Annual)$1.51
Current Ratio (Annual)2.14x
Quick Ratio (Quarterly)0.92x
3-Month Avg Trading Volume0.54M
52-Week Price Return-18.63%
EV / Free Cash Flow (Annual)13.25x
P/E Incl Extra (TTM)25.61x
Revenue / Employee (TTM)$0
Tangible BV / Share (Quarterly)$14.56
P/S Ratio (Annual)0.88x
Asset Turnover (Annual)0.59x
52-Week High$61.08
Operating Margin (5Y Avg)8.01%
EPS Excl Extra (Annual)$1.51
CapEx CAGR (5Y)8.79%
Tangible BV CAGR (5Y)16.79%
26-Week Price Return-8.43%
Quick Ratio (Annual)0.92x
13-Week Price Return-6.01%
Total Debt / Equity (Annual)0.81x
Current Ratio (Quarterly)2.14x
Enterprise Value$1,999.1
Revenue / Share Growth (5Y)8.58%
Asset Turnover (TTM)0.59x
Book Value / Share Growth (5Y)6.33%
Revenue / Employee (Annual)$0
Inventory Turnover (Annual)1.81x
Pretax Margin (Annual)5.17%
Cash / Share (Annual)$1.32
3-Month Return Std Dev39.85%
Gross Margin (5Y Avg)55.02%
Net Income / Employee (TTM)$0
EBITDA CAGR (5Y)11.01%
EBITDA Interim CAGR (5Y)6.29%
ROE (Last FY)4.55%
Net Interest Coverage (Annual)3.29x
EPS Basic Excl Extra (Annual)$1.51
P/FCF (TTM)7.99x
Receivables Turnover (TTM)5.66x
EV / Free Cash Flow (TTM)13.25x
Total Debt / Equity (Quarterly)0.81x
EPS Incl Extra (TTM)$1.51
Receivables Turnover (Annual)5.66x
ROI (TTM)2.51%
Dividend Growth Rate (5Y)0.10%
P/S Ratio (TTM)0.88x
Pretax Margin (5Y Avg)4.92%
Revenue / Share (Annual)$44.13
Tangible BV / Share (Annual)$14.56
Forward P/E8.97x
Free OCF CAGR (5Y)23.98%
Price vs S&P 500 (52W)-53.73%
P/E Ratio (TTM)25.61x
EPS Growth TTM (YoY)-64.70%
Year-to-Date Return-3.74%
5-Day Price Return1.61%
EPS Normalized (Annual)$1.51
ROA (5Y Avg)2.12%
Net Profit Margin (Annual)3.42%
Month-to-Date Return10.52%
Cash Flow / Share (TTM)$4.16
EBITD / Share (Annual)$4.41
Operating Margin (Annual)7.46%
LT Debt / Equity (Annual)0.81x
P/CF (TTM)7.06x
ROI (5Y Avg)2.59%
P/E Excl Extra (TTM)25.61x
LT Debt / Equity (Quarterly)0.81x
EPS Basic Excl Extra (TTM)$1.51
P/TBV (Quarterly)2.79x
Payout Ratio (Annual)52.59%
P/B Ratio (Annual)1.22x
Dividend / Share (TTM)$0.80
Inventory Turnover (TTM)1.78x
Pretax Margin (TTM)5.17%
Book Value / Share (Annual)$33.36
Price vs S&P 500 (13W)-8.88%
Net Margin Growth (5Y)25.47%
Dividend Yield (TTM)2.05%
Beta1.01x
P/FCF (Annual)7.99x
Revenue / Share (TTM)$44.12
ROE (TTM)4.68%
52-Week Low$33.21
Analyst Recommendations
Jan 2026
Feb 2026
Mar 2026
Apr 2026
3.67
3.67
3.67
2.55
Industry Peers — Electromedical Equipment(29)
| Symbol | P/S Ratio (TTM) | Revenue Growth (5Y) | Gross Margin (TTM) | Operating Margin (TTM) | Price |
|---|---|---|---|---|---|
CNMDCONMED Corporation | 0.88x | 9.77% | 54.59% | 7.46% | $39.08 |
MDTMedtronic plc | 3.12x | 3.01% | 65.16% | 17.00% | $86.19 |
MASIMasimo Corporation | 6.12x | 5.95% | 61.90% | 20.30% | $178.39 |
TMDXTransMedics Group, Inc. Common Stock | 6.56x | 88.21% | 59.92% | 17.93% | $115.87 |
LIVNLivaNova PLC Ordinary Shares | 2.64x | 8.24% | 68.04% | 14.09% | $67.12 |
ITGRInteger Holdings Corporation | 1.67x | 11.55% | 27.39% | 11.90% | $90.20 |
AXGNAxogen, Inc. Common Stock | 8.87x | 14.93% | 74.31% | -3.49% | $38.50 |
BLFSBioLife Solutions Inc. | 10.79x | 14.87% | 64.56% | -17.26% | $21.50 |
INMDInMode Ltd. Ordinary Shares | 2.51x | 12.45% | 78.54% | 23.05% | $14.65 |
CBLLCeriBell, Inc. Common Stock | 8.77x | — | 87.89% | -65.57% | $21.19 |
CVCapsoVision, Inc. Common Stock | 22.10x | — | 52.92% | -188.25% | $6.01 |
About
CONMED Corporation is a medical technology company that designs and manufactures surgical devices and equipment for multiple specialties, including orthopedic, general, gynecological, thoracic, and gastroenterological procedures. The company serves surgeons and healthcare professionals globally, with operations spanning North America, Europe, the Middle East, Africa, and Asia-Pacific. The United States represents CONMED's largest market and primary revenue driver.